Inivata
Cambridge
About Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $164.4M
- Funding stage: M&A
- Last round: Series C (Feb 2021)
- Website: inivata.com
- Phone: (440) 207-6389
Industries & Categories
Biotechnology, Genetics, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/inivata-54956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.